[Skip to Navigation]
August 1967

Changing Concepts Concerning the Malignancy of Ocular Tumors

Author Affiliations

Washington, DC
From the Registry of Ophthalmic Pathology, Armed Forces Institute of Pathology, Washington, DC.

Arch Ophthalmol. 1967;78(2):166-173. doi:10.1001/archopht.1967.00980030168009

Histopathologic studies correlated with longterm follow-up investigations have led to a change in the prognosis and management of certain ocular tumors. The relative benignancy of certain tumors of the uvea, conjunctiva, eyelid, orbit, and lacrimal gland has become widely appreciated, and efforts are being made to develop more conservative techniques in their treatment. Other tumors are being recognized as highly malignant cancers requiring early radical surgery if the patient's life is to be saved. The more enlightened management of ocular neoplasms, based on our better knowledge of their biological behavior, constitutes one of the major advances that has been made in clinical ophthalmology.

Add or change institution